Use of cannabidiol in the treatment of autoimmune hepatitis
Methods of treating autoimmune hepatitis are provided. The methods include injecting cannabidiol into the subject, where the cannabidiol is synthetic cannabidiol or natural cannabidiol isolated from other natural cannabinoids.
1. A method of treating autoimmune hepatitis in a subject, the method comprising:
identifying a subject suffering from autoimmune hepatitis; and
injecting cannabidiol into the subject; wherein said cannabidiol is synthetic cannabidiol or natural cannabidiol isolated from other natural cannabinoids.
2. The method as in claim 1 , wherein said cannabidiol is injected to the subject substantially free of any psychotropic agent.
3. The method as in claim 1 , wherein said cannabidiol is injected to the subject substantially free of Δ 9 -tetrahydrocannabinol.
4. The method as in claim 1 further comprising providing said cannabidiol in a drug delivery vehicle.
5. The method as in claim 4 , wherein the drug delivery vehicle is a sustained release drug delivery vehicle.
6. The method as in claim 1 , wherein the method is an in vivo therapeutic treatment method.